Facebook Twitter LinkedIn
Board of Directors
Board of Directors
Policy Fellows
Institutes & Affiliates
1130 K Street, Suite 280, Sacramento, CA, 95814-3965, (916) 492-0996
Support CCST


James L. Sweeney (Council Chair)
Stanford University
Judith Swain (Council Vice Chair)
National University of Singapore
Lori Bettison-Varga
Natural History Museum
Dona Crawford
Lawrence Livermore National Laboratory
Jeff Dozier
UC Santa Barbara
Ziyad "Zee" Duron
Harvey Mudd College
Susan Hackwood (Executive Director) CCST
Bryan Hannegan
Holy Cross Energy
Susan Hubbard
Lawrence Berkeley National Laboratory
Michael Kavanaugh
Geosyntec Consultants, Inc.
Regis Kelly
QB3 Institute
Charles Kolstad
Stanford University
Patrick Lee
Sempra Energy
Henry Lester
California Institute of Technology
Jane Long
Climate Strategist
Amber Mace
Michael Norman
San Diego Supercomputer Center
Prasad Ram
Steven Schroeder
Linda Dairiki Shortliffe, MD
Stanford University
Dan Sperling
UC Davis
Joseph Walkush
Science Applications International Corporation
Yulun Wang
InTouch Health
Judy Swain, MD

CCST Council Vice Chair
Judith L. Swain, MD

Executive Director, Singapore Institute for Clinical Sciences, Agency for Science, Technology, and Research (A*STAR); Lien Ying Chow Professor of Medicine, Yong Loo Lin School of Medicine, National University of Singapore; Adjunct Professor of Medicine, UC San Diego

Dr. Judith L. Swain is currently Executive Director of the Singapore Institute for Clinical Sciences Agency for Science, Technology and Research, the Lien Ying Chow Professor of Medicine at the Yong Loo Lin School of Medicine, National University of Singapore, and Adjunct Professor of Medicine at UC San Diego. Previously she served as the Founding Executive Director of the Singapore Institute for Clinical Sciences within A*STAR.

Prior to coming to Singapore she was the Dean for Translational Medicine and the Founding Director of the College of Integrated Life Sciences (COILS) at the University of California, San Diego. Dr. Swain previously served as Chair of the Department of Medicine at Stanford University and held the Arthur Bloomfield and George E. Becker Professorships there. Prior to her appointment at Stanford, she was the Herbert C. Rorer Professor of Medical Sciences, Professor of Genetics, and Director of Cardiovascular Medicine at the University of Pennsylvania. Dr. Swain received her undergraduate education at the University of California, Los Angeles, and her medical education at the University of California, San Diego.

She trained in Internal Medicine and Cardiovascular Medicine at Duke University. She then joined the faculty at Duke where she became widely known in the field of molecular cardiology, and pioneered the use of transgenic animals to understand the genetic basis of cardiovascular development and disease. Her current research interests are centered on assessing and enhancing human performance in extreme environments. She co-founded a center (OptiBrain) with the goal of optimizing brain resources for performance in extreme environments. This center is collaboration between UC San Diego and the Naval Health Research Center (San Diego).

In Singapore, Dr. Swain serves on the Board of Directors of the National Healthcare Group, and on the Board Committee overseeing the Institute of Mental Health. She also serves on the Governing Council of the Lee Kong Chian School of Medicine, Imperial College/NTU, and on the Academic Oversight Committee of that Council. Dr. Swain has served in a number of national leadership roles in the U.S., including President of the American Society for Clinical Investigation, President of the American Association of Physicians, and an elected member of the Council of the Institute of Medicine. She served on the NIH Director’s Standing Committee on Clinical Research, the NIH National Advisory Research Resources Council and the NRC Commission to evaluate the organization of the National Institutes of Health. She served as a member of the Defense Science Research Council of DARPA, on the Board on Army Science and Technology, and as Chair of the Triennial Army Lifesciences and Medical Laboratory Review for the Assistant Secretary of the Army for Science and Technology. Dr. Swain has served on international advisory committees including those of the Wellcome Trust, the British Heart Association, the UK Medical Research Council, and the Canadian Foundation for Innovation. She is currently a Director of Lexicon Pharmaceuticals and of Avacen, Inc., a member of the SAB for the Wyss Institute for Biologically Inspired Engineering at Harvard, and a member of the Scientific Advisory Committee of the Qatar Biomedical Sciences Institute. She serves or has served as a director or a SAB member for a number of biomedical technology companies, and is co-founder of Synecor, LLC a medical device accelerator. Dr. Swain has been elected to a number of honorary societies including the Association of American Physicians, the American Society for Clinical Investigation, Fellow of the American Association for the Advancement of Science, and the Institute of Medicine.

Updated 5/5/17